Article metrics

Concise report
Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: September 2015 to October 2019

AbstractFullPdf
Sep 2015868261571
Oct 2015178165194
Nov 2015654180443
Dec 2015263141171
Jan 201699164141
Feb 2016120137133
Mar 20161129287427
Apr 2016633219239
May 2016369141119
Jun 201619314996
Jul 20161627770
Aug 201610510978
Sep 2016939775
Oct 201610710197
Nov 2016969367
Dec 2016836959
Jan 20178510285
Feb 2017246542
Mar 2017279463
Apr 2017910633
May 20171315290
Jun 2017379356
Jul 20171049735
Aug 201710510034
Sep 20171109639
Oct 201712011751
Nov 2017958537
Dec 2017897537
Jan 201811811755
Feb 20181029154
Mar 201811110046
Apr 20181098529
May 201816514784
Jun 2018957840
Jul 2018836727
Aug 2018837541
Sep 2018938929
Oct 2018505028
Nov 20181019244
Dec 2018686635
Jan 2019635745
Feb 2019686764
Mar 2019817043
Apr 20191038267
May 2019847745
Jun 2019624646
Jul 2019665758
Aug 2019675847
Sep 2019604636
Oct 2019666139
Total786852504584